Tags: Consumer Trendsconsumer-trendsTrendsHolidaysholiday-shopping-season
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | The Conversation Science Alert Science news. Official account. Australia | New Non-Opioid Painkiller First in Decades to Win FDA Approval - about 2 months ago First-of-Its-Kind Trial Gives New Hope For Treating Multiple Sclerosis - over 1 year ago | |
| 2 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | New Bispecific Shrinks NRG1 Fusion-Positive Lung, Pancreatic Tumors - about 2 months ago | |
| 3 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | NICE endorses Neuraxpharm’s ublituximab for treating MS - 4 months ago | |
| 4 | Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. | ||
| 5 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland | ||
| 6 | Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. | New Data on CD40 Ligand Inhibitor for Relapsing MS - over 1 year ago | |
| 7 | Emily Cooke Live Science Health reporter. London, United Kingdom | These 3 neurons may underlie the drive to eat food - 5 months ago | |
| 8 | Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
| 9 | Aparna Nathan, PhD The Scientist Single-cell genetics researcher.
Teaches at Harvard.
Writes for PopSci.
Contributes to Drug Discovery News. Boston, Massachusetts | Combating Age-Related Motor Decline - 7 months ago | |
| 10 | Meagan Parrish Pharma Voice Senior editor @industrydive.
Pharma world follower. Wisconsin, USA | Neuro drugs are still faltering, despite rising investment - 8 months ago Neurvati touts fresh, ‘synergistic’ investment model in neuroscience R&D - about 1 year ago |